Dr. Pavlo Lukyanchykov, MD

Dr. Lukyanchykov practices at Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health.

Dr. Lukyanchykov's NPI, 1831572510, was assigned on June 30, 2015. Dr. Lukyanchykov graduated from Vinnica State Medical University in 2008. Dr. Lukyanchykov holds Florida license ME136126.

Dr. Lukyanchykov's primary practice is Holy Cross Health, at 4725 N Federal Hwy, Fort Lauderdale, FL 33308 in Broward County. The practice phone is (954) 771-8000.

Dr. Lukyanchykov's primary practice is Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health. Dr. Lukyanchykov is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Florida Hospital Medicine Services, Llc. Dmand AI also links Dr. Lukyanchykov to 4 more medical groups, 3 home health agencies and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lukyanchykov practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lukyanchykov's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lukyanchykov is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lukyanchykov's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists acute diabetes, acute respiratory failure, arthritis, atrial fibrillation and flutter, bone infection, cardiac arrhythmia, cellulitis and chronic kidney disease among the conditions Dr. Lukyanchykov treats.

CMS data shows 1,190 Medicare services from Dr. Lukyanchykov across 7 procedure codes in 2024, for 492 Medicare patients. Medicare paid $114,949 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 492 Medicare patients who saw Dr. Lukyanchykov in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lukyanchykov's median patient age at 71, with 45% women.

In 2024, Dr. Lukyanchykov wrote 786 Medicare Part D claims for 291 patients. 86% of them were for generic drugs. CMS names the drug for 423 of them, across 19 drugs with 11 or more claims each, at $29,518 in total drug cost. In 2023, CMS named 302 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Lukyanchykov for performance year 2024, reported through an alternative payment model (APM). Dr. Lukyanchykov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lukyanchykov as offering telehealth.

Dmand AI links 2 papers to Dr. Lukyanchykov in 2018. The most frequent topics are T-Lymphocytes, Regulatory. Dr. Lukyanchykov's most frequent co-authors are Jamil R. Azzi, MD, Peter Leif Bergsagel, MD and Tarek Hassaan Mouhieddine, MD.

CMS Open Payments shows 53 general payments to Dr. Lukyanchykov from 6 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,844.

Dr. Lukyanchykov graduated from Vinnica State Medical University in 2008. Dr. Lukyanchykov is a member of SHM.

Dr. Lukyanchykov is in network with 10 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.